ライフサイエンスコーパス: routine immunization

1 irus are safe, effective and recommended for routine immunization.

2 vated poliovirus vaccine and bivalent OPV in routine immunization.

3 sed respiratory support and intubation after routine immunization.

4 gns and 3 trivalent OPV (tOPV) doses through routine immunization.

5 %) for including safe injection equipment in routine immunization.

6 oduced fewer local reactions than concurrent routine immunizations.

7 tries after administration of SP-IPTi during routine immunizations.

8 d a control district where workers conducted routine immunization activities without health behavior

9 tration and defaulter tracing, monitoring of routine immunization activities, and support of district

10 aining high vaccination coverage through the routine immunization activity infrastructure, thus creat

11 ) improving outbreak response, (5) enhancing routine immunization and activities implemented between

12 dministering oral poliovirus vaccine through routine immunization and annual national immunization da

13 Rotary is providing additional support for routine immunization and healthcare.

14 but later expanded its messaging to promote routine immunization and other health and sanitation int

15 ovirus vaccine or exposure to OPV virus from routine immunization and recent injections could explain

16 sider introducing a fIPV strategy into their routine immunization and supplementary immunization acti

17 s to questions about health behaviors during routine immunizations and providing targeted counseling.

18 of national immunization days, strengthening routine immunization, and carrying-out mopping-up activi

19 acute flaccid paralysis (AFP) surveillance, routine immunization, and polio supplemental immunizatio

20 The objective includes strengthening routine immunization as the primary pillar to sustaining

21 Routine immunization at 9 months of age resulted in lowe

22 r); (2) preventive vaccination campaign; (3) routine immunization at 9 months; and (4) a combination

23 ful policy dialogue about polio vaccines and routine immunization at multiple levels.

24 f experience integrating other services with routine immunization at outreach sessions.

25 l vaccine (group 3; n=62), administered with routine immunizations at 2, 3, and 4 months of age.

26 e settings, vaccination campaigns supplement routine immunization but often fail to achieve coverage

27 lation received smallpox vaccinations before routine immunization ceased in 1972 for civilians and in

28 Infants received routine immunization: combination diphtheria vaccine (di

29 Routine immunization could be strengthened in areas wher

30 surveillance starting in 2004; and conducted routine immunization coverage and seroprevalence surveys

31 h-risk pockets witnessed an increase in full routine immunization coverage.

32 ter OPV cessation in areas with insufficient routine immunization coverage.

33 ecommendations for improved surveillance and routine immunization during the health system decentrali

34 The practice of routine immunization has reshaped our view of pediatric

35 the growing neglect of societal adherence to routine immunizations has prompted the Medical Advisory

36 ctivities in 236 districts, and strengthened routine immunization in 100 districts.

37 ation and city location were associated with routine immunization in August 2000 (71% vs 25% [P =.003

38 tivated poliovirus vaccine, strengthening of routine immunization in countries with extensive polio r

39 of this conjugate vaccine concurrently with routine immunization in infants is planned.

40 iew Committee (ERC) on Polio Eradication and Routine Immunization in Nigeria recommended that social

41 ch efforts should also be adopted to support routine immunization, introduction of new vaccines, and

42 Pakistan, and children remain at risk unless routine immunization is strengthened or additional suppl

43 building in countries where surveillance and routine immunization lag behind other health priorities.

44 Cases were undervaccinated through routine immunization (matched odds ratio [MOR], 0.3; 95%

45 s vaccines are available and recommended for routine immunization of all infants.

46 Routine immunization of children has the potential to re

47 Routine immunization of children with the heptavalent pn

48 rus vaccine (RV1) with intussusception after routine immunization of infants in Mexico and Brazil.

49 type b conjugate vaccines were licensed for routine immunization of infants.

50 cine is recommended in the United States for routine immunization of infants.

51 PV in countries currently using OPV only for routine immunization offers protection from paralysis to

52 cellular pertussis vaccine either as part of routine immunization or for outbreak control should be e

53 sitant to vaccinate their children may delay routine immunizations or seek exemptions from state vacc

54 rveillance, vaccination campaigns, increased routine immunization outreach sessions, and strengthenin

55 data management, alternatives for measuring routine immunization performance should be considered.

56 ution model to explore the impact of various routine immunization policies involving IPV on populatio

57 Hygiene kit distribution during routine immunizations positively impacted household wate

58 ad range of circulating strains as part of a routine immunization program >5 years after its introduc

59 eria because of low coverage achieved in the routine immunization program and in supplementary immuni

60 by NITAGs in the introduction of IPV in the routine immunization program and the lessons learned.

61 cine (IPV) at >/=14 weeks of age through the routine immunization program in countries currently not

62 The routine immunization program information collected inclu

63 16, 11 EMR countries introduced IPV in their routine immunization program, including all of the count

64 rform critical tasks in the strengthening of routine immunization programs and the control of measles

65 Strengthened routine immunization programs in countries with suboptim

66 of inactivated polio vaccine (IPV) into the routine immunization programs of all countries using ora

67 entifying gaps in the polio surveillance and routine immunization programs, and provided recommendati

68 ng with the type 2 component; and strengthen routine immunization programs-set an ambitious series of

69 ns and to begin vaccine safety monitoring in routine immunization programs.

70 ta management and quality, and strengthening routine immunization programs.

71 ation and the implications for triggered and routine immunization programs.

72 zone impedes the establishment of effective routine immunization programs.

73 ontrol strategy coupled with the delivery of routine immunizations recommended by the World Health Or

74 frica and the WHO Executive Board to ramp up routine immunization (RI) activities, began to intensify

75 nts at high risk for polio transmission with routine immunization (RI) and other selected primary hea

76 he impact of polio eradication activities on routine immunization (RI) and primary healthcare (PHC).

77 m was undertaken, with specific focus on the routine immunization (RI) component.

78 ing, and a renewed emphasis on strengthening routine immunization (RI) programs.

79 ced inactivated polio vaccine (IPV) into its routine immunization (RI) schedule in March 2015 and was

80 The potential to strengthen routine immunization (RI) services through supplementary

81 Recent changes in the routine immunization schedule and a renewed emphasis on

82 Adding a single IPV dose to an OPV-only routine immunization schedule at or just before OPV cess

83 d dose of varicella vaccine was added to the routine immunization schedule for children in June 2006

84 accine (IPV) after its introduction into the routine immunization schedule in Bangladesh.

85 us (HPV) vaccination was introduced into the routine immunization schedule in the United States in la

86 introduction of the varicella vaccine to the routine immunization schedule, we have observed a 70% re

87 2002, as PCV7 was being introduced into the routine immunization schedule.

88 ng injectable vaccines delivered through the routine immunization schedule: diphtheria-tetanus-pertus

89 f inactivated polio vaccine (IPV) into their routine immunization schedules by the end of 2015.

90 dose of Inactivated Polio Vaccine (IPV) into routine immunization schedules by the end of 2015.

91 ntroduction of at least one dose of IPV into routine immunization schedules in 126 all OPV-using coun

92 dose of inactivated poliovirus vaccine into routine immunization schedules, and it describes the pro

93 Opportunities to strengthen the routine immunization service and health system should be

94 nsider funding to maintain and to strengthen routine immunization services and other maternal, neonat

95 eradication goal is its potential impact on routine immunization services and the overall health sys

96 This legacy also includes support for routine immunization services and vaccine introductions

97 zation campaigns, and the urgency to improve routine immunization services.

98 s in vaccination campaigns and strengthening routine immunization services.

99 icators associated with AFP surveillance and routine immunization, showing statistically significant

100 prompt detection of outbreaks, but its weak routine immunization system means that supplementary imm

101 Efforts are underway to strengthen Nigeria's routine immunization system, yet measuring impact poses

102 n immunity than can be achieved in a growing routine immunization system.

103 lenges include a decline in funding and weak routine immunization systems in some countries.

104 Limited resources for surveillance and routine immunization systems in the region indicate a ri

105 have received to conduct tasks to strengthen routine immunization systems, and the type of tasks they

106 VIs can provide an opportunity to strengthen routine immunization, through strengthening program mana

107 introduction of inactivated polio vaccine in routine immunization to mitigate against risk of vaccine

108 Routine immunization using the meningococcal conjugate v

109 airs were enrolled at presentation for their routine immunization visit in Soweto, South Africa, when

110 n 10,095 children 1 to 2 years of age during routine immunization visits.

111 Failure to vaccinate through routine immunization was a major risk factor for poliomy

112 Planning started early, routine immunization was strengthened, and technical and

113 isseminated vaccine strain measles following routine immunization, whereas an infant brother died aft

114 Routine immunization with 2 full or fractional doses of

115 In future, how might intensive, routine immunization with novel vaccines compare against

116 Between 2015 and 2035, routine immunization with or without a catch-up campaign

117 Routine immunization with pneumococcal conjugate vaccine

118 s, acute flaccid paralysis surveillance, and routine immunization with the support of the surge capac